Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03641378 · ClinicalTrials.gov registry record · NA
Inpatient Palliative Care for Patients Undergoing Hematopoietic Stem Cell Transplantation
A NA study of Stem Cell Transplant, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 546
- Enrollment target
- 3
- Study locations
NCT03641378 is a NA study of Stem Cell Transplant that has completed, run by Massachusetts General Hospital. The registered enrollment target is 546 participants, above the 136-participant average among 9 other Stem Cell Transplant trials with a reported enrollment target (301% higher). The trial reports 3 study locations across 3 states.
The verdict
NCT03641378, a NA study of Stem Cell Transplant, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 546 participants
- Enrollment target
- 3
- Study locations
Study Summary
This research study is evaluating the impact of early involvement of a palliative care team working with the transplant oncology team will have on the quality of life, symptoms, and mood of patients undergoing stem cell transplantation.
Conditions Studied
Interventions
- OTHER Palliative Care Intervention
- OTHER Standard Transplant Care
Study Locations (3)
Massachusetts
- Massachusetts General Hospital - Boston
North Carolina
- Duke University - Durham
Washington
- Fred Hutchinson Cancer Research Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 546 participants |
| Start Date | 2018-09-30 |
| Est. Completion | 2023-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03641378
The ClinicalTrials.gov registry entry for NCT03641378 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 546 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 136-participant average among 9 other Stem Cell Transplant trials with a reported enrollment target (301% higher). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Stem Cell Transplant appearing as the primary indexed condition, and to 2 interventions - of which Palliative Care Intervention is the first listed.
NCT03641378 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Massachusetts, North Carolina, Washington.
Frequently Asked Questions
What is clinical trial NCT03641378 about?
NCT03641378 is a clinical study titled "Inpatient Palliative Care for Patients Undergoing Hematopoietic Stem Cell Transplantation". This research study is evaluating the impact of early involvement of a palliative care team working with the transplant oncology team will have on the quality of life, symptoms, and mood of patients undergoing stem cell transplantation.
What is the current status of trial NCT03641378?
This trial is currently completed. It is a NA study. The enrollment target is 546 participants. The study started on 2018-09-30. Estimated completion is 2023-07-01.
What conditions does trial NCT03641378 study?
This clinical trial studies the following conditions: Stem Cell Transplant.
What interventions are being tested in trial NCT03641378?
The interventions under investigation include: Palliative Care Intervention (OTHER), Standard Transplant Care (OTHER).
Who is sponsoring clinical trial NCT03641378?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03641378 being conducted?
This trial has 3 study locations across Massachusetts, North Carolina, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stem Cell Transplant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Psychosocial and Behavioral Intervention for Stem Cell Transplant Patients and Their Family Caregivers
RECRUITING · NA
-
Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection
RECRUITING · NA
-
Behavioral Weight Loss Intervention Utilizing Mobile Health Technology in Hematopoietic Stem Cell Transplant Patients
RECRUITING · NA
-
BMT4me: Post-HSCT Medication Adherence mHealth App
RECRUITING · NA
-
Mosaic Trial for Stem Cell Transplant Recipients
RECRUITING · NA
-
Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.